Has anyone else noticed how vapid the New York Times‘ editorials on the flu vaccine are? Their editorial last October bemoaned the paucity of vaccine manufacturers but did not not suggest anything–not one thing–that would attract more manufacturers to the market. Today the Times revisits the issue, repeating the platitude that “the vaccine manufacturing process must be made more reliable” but again offering no solutions.

Does anyone take this drivel seriously?